Back to Search
PHILIP LIVINGSTON, MD
MD
Medical Oncology Physician
NPI: 1295831394Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
107012(NY)
Research & Publications (20)
Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
PMID 15926079·Cancer Immunol Immunother·2005
8-other
Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues.
PMID 10821459·J Clin Immunol·2000
6-review
The psychological impact of a specialist referral and telephone intervention on male cancer patients: a randomised controlled trial.
PMID 19673008·Psychooncology·2010
2-rct
Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.
PMID 19253940·J Am Chem Soc·2009
8-other
From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
PMID 19518111·J Am Chem Soc·2009
7-preclinical
Adolescents' use of purpose built shade in secondary schools: cluster randomised controlled trial.
PMID 19223344·BMJ·2009
4-observational
Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
PMID 19190907·Cancer Immunol Immunother·2009
7-preclinical
How much do we know about the determinants of physical activity among prostate cancer survivors? Directions for future research to inform interventions.
PMID 19413866·Aust N Z J Public Health·2009
8-other
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
PMID 18797450·Mol Ther·2008
3-trial
Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.
PMID 18624313·Angew Chem Int Ed Engl·2008
7-preclinical
Evaluation of widely consumed botanicals as immunological adjuvants.
PMID 18640165·Vaccine·2008
7-preclinical
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.
PMID 17726460·Mol Ther·2007
2-rct
The diversity of emergency code telephone numbers in Australian hospitals: the feasibility of an Australian standard emergency code.
PMID 17973612·Aust Health Rev·2007
8-other
Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
PMID 17634545·Clin Cancer Res·2007
8-other
Australian adolescents' sun protection behavior: who are we kidding?
PMID 17400286·Prev Med·2007
8-other
A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.
PMID 17420942·Dig Dis Sci·2007
3-trial
Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
PMID 17504999·Clin Cancer Res·2007
3-trial
Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.
PMID 17570567·Vaccine·2007
4-observational
A polyvalent vaccine for high-risk prostate patients: "are more antigens better?".
PMID 17619878·Cancer Immunol Immunother·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3275
Quick Facts
- NPI
- 1295831394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile